메뉴 건너뛰기




Volumn 204, Issue 6, 2012, Pages 895-901

A novel combination of withaferin A and sorafenib shows synergistic efficacy against both papillary and anaplastic thyroid cancers

Author keywords

Anaplastic thyroid cancer; Novel therapy; Papillary thyroid cancer; Sorafenib; Synergistic effects; Withaferin A

Indexed keywords

B RAF KINASE; CASPASE 3; RAF PROTEIN; SORAFENIB; WITHAFERIN A;

EID: 84870975246     PISSN: 00029610     EISSN: 18791883     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2012.07.027     Document Type: Article
Times cited : (52)

References (20)
  • 2
    • 0003964361 scopus 로고    scopus 로고
    • American Cancer Society American Cancer Society, Inc Atlanta, GA
    • American Cancer Society Cancer Facts and Figures 2011 2011 American Cancer Society, Inc Atlanta, GA
    • (2011) Cancer Facts and Figures 2011
  • 3
    • 0036069260 scopus 로고    scopus 로고
    • Management of papillary and follicular thyroid cancer
    • M.K. Jones Management of papillary and follicular thyroid cancer J R Soc Med 95 2002 325 326
    • (2002) J R Soc Med , vol.95 , pp. 325-326
    • Jones, M.K.1
  • 4
    • 0031723678 scopus 로고    scopus 로고
    • Management of the patient with progressive radioiodine non-responsive disease
    • B.R. Haugen Management of the patient with progressive radioiodine non-responsive disease Semin Surg Oncol 16 1999 34 41
    • (1999) Semin Surg Oncol , vol.16 , pp. 34-41
    • Haugen, B.R.1
  • 5
    • 34248232601 scopus 로고    scopus 로고
    • An evidence-based review of poorly differentiated thyroid cancer
    • E.M. Sanders Jr, V.A. LiVolsi, J. Brierley An evidence-based review of poorly differentiated thyroid cancer World J Surg 31 2007 934 945
    • (2007) World J Surg , vol.31 , pp. 934-945
    • Sanders, Jr.E.M.1    Livolsi, V.A.2    Brierley, J.3
  • 6
    • 0038695856 scopus 로고    scopus 로고
    • Surgical treatment of medullary thyroid carcinoma
    • M.S. Cohen, J.F. Moley Surgical treatment of medullary thyroid carcinoma J Intern Med 253 2003 616 626
    • (2003) J Intern Med , vol.253 , pp. 616-626
    • Cohen, M.S.1    Moley, J.F.2
  • 7
    • 33646506360 scopus 로고    scopus 로고
    • Drug insight: Small-molecule inhibitors of protein kinases in the treatment of thyroid cancer
    • M. Santoro, F. Carlomagno Drug insight: small-molecule inhibitors of protein kinases in the treatment of thyroid cancer Nat Clin Pract Endocrinol Metab 2 2006 42 52
    • (2006) Nat Clin Pract Endocrinol Metab , vol.2 , pp. 42-52
    • Santoro, M.1    Carlomagno, F.2
  • 8
    • 21244457181 scopus 로고    scopus 로고
    • BRAF mutation in thyroid cancer
    • M. Xing BRAF mutation in thyroid cancer Endocr Relat Cancer 12 2005 245 262
    • (2005) Endocr Relat Cancer , vol.12 , pp. 245-262
    • Xing, M.1
  • 9
    • 30144437331 scopus 로고    scopus 로고
    • Oncogenic rearrangements of the NTRK1/NGF receptor
    • M.A. Pierotti, A. Greco Oncogenic rearrangements of the NTRK1/NGF receptor Cancer Lett 232 2006 90 98
    • (2006) Cancer Lett , vol.232 , pp. 90-98
    • Pierotti, M.A.1    Greco, A.2
  • 10
    • 28544452359 scopus 로고    scopus 로고
    • Mutation of the PIK3CA gene in anaplastic thyroid cancer
    • G. García-Rostán, A.M. Costa, I. Pereira-Castro Mutation of the PIK3CA gene in anaplastic thyroid cancer Cancer Res 65 2005 10199 10207
    • (2005) Cancer Res , vol.65 , pp. 10199-10207
    • García-Rostán, G.1    Costa, A.M.2    Pereira-Castro, I.3
  • 11
    • 84863283404 scopus 로고    scopus 로고
    • Molecular targeted therapies for cancer: Sorafenib mono-therapy and its combination with other therapies
    • N. Ibrahim, Y. Yu, W.R. Walsh Molecular targeted therapies for cancer: sorafenib mono-therapy and its combination with other therapies Oncol Rep 27 2012 1303 1311
    • (2012) Oncol Rep , vol.27 , pp. 1303-1311
    • Ibrahim, N.1    Yu, Y.2    Walsh, W.R.3
  • 12
    • 34247857540 scopus 로고    scopus 로고
    • Safety, pharmacokinetics, and preliminary antitumor activity of sorafenib: A review of four phase i trials in patients with advanced refractory solid tumors
    • D. Strumberg, J.W. Clark, A. Awada Safety, pharmacokinetics, and preliminary antitumor activity of sorafenib: a review of four phase I trials in patients with advanced refractory solid tumors Oncologist 12 2007 426 437
    • (2007) Oncologist , vol.12 , pp. 426-437
    • Strumberg, D.1    Clark, J.W.2    Awada, A.3
  • 13
    • 70549099893 scopus 로고    scopus 로고
    • A novel HSP90 modulator with selective activity against thyroid cancers in vitro
    • A. Samadi, P. Loo, R. Mukerji A novel HSP90 modulator with selective activity against thyroid cancers in vitro Surgery 146 2009 1196 1207
    • (2009) Surgery , vol.146 , pp. 1196-1207
    • Samadi, A.1    Loo, P.2    Mukerji, R.3
  • 15
    • 34548682302 scopus 로고    scopus 로고
    • Withanolide A biogeneration in in vitro shoot cultures of ashwagandha (Withania somnifera DUNAL), a main medicinal plant in Ayurveda
    • R.S. Sangwan, N.D. Chaurasiya, P. Lal Withanolide A biogeneration in in vitro shoot cultures of ashwagandha (Withania somnifera DUNAL), a main medicinal plant in Ayurveda Chem Pharm Bull 55 2007 1371 1375
    • (2007) Chem Pharm Bull , vol.55 , pp. 1371-1375
    • Sangwan, R.S.1    Chaurasiya, N.D.2    Lal, P.3
  • 16
    • 39049145298 scopus 로고    scopus 로고
    • Withanolides from Withania somnifera roots
    • L. Misra, P. Mishra, A. Pandey Withanolides from Withania somnifera roots Phytochemistry 69 2008 1000 1004
    • (2008) Phytochemistry , vol.69 , pp. 1000-1004
    • Misra, L.1    Mishra, P.2    Pandey, A.3
  • 17
    • 34248531954 scopus 로고    scopus 로고
    • Cytotoxic withanolides from Physalis angulata L
    • Q.P. He, L. Ma, J.Y. Luo Cytotoxic withanolides from Physalis angulata L Chem Biodivers 4 2007 443 449
    • (2007) Chem Biodivers , vol.4 , pp. 443-449
    • He, Q.P.1    Ma, L.2    Luo, J.Y.3
  • 18
    • 78649785240 scopus 로고    scopus 로고
    • Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera's key metabolite withaferin A
    • A. Grover, A. Shandilya, A. Punetha Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera's key metabolite withaferin A BMC Genomics 11 Suppl 4 2010 S25
    • (2010) BMC Genomics , vol.11 , Issue.SUPPL. 4 , pp. 25
    • Grover, A.1    Shandilya, A.2    Punetha, A.3
  • 19
    • 78649781036 scopus 로고    scopus 로고
    • Probing the anticancer mechanism of prospective herbal drug Withaferin A on mammals: A case study on human and bovine proteasomes
    • A. Grover, A. Shandilya, V.S. Bisaria Probing the anticancer mechanism of prospective herbal drug Withaferin A on mammals: a case study on human and bovine proteasomes BMC Genomics 11 Suppl 4 2010 S15
    • (2010) BMC Genomics , vol.11 , Issue.SUPPL. 4 , pp. 15
    • Grover, A.1    Shandilya, A.2    Bisaria, V.S.3
  • 20
    • 77957223466 scopus 로고    scopus 로고
    • Withaferin A, a cytotoxic steroid from Vassobia breviflora, induces apoptosis in human head and neck squamous cell carcinoma
    • A.K. Samadi, X. Tong, R. Mukerji Withaferin A, a cytotoxic steroid from Vassobia breviflora, induces apoptosis in human head and neck squamous cell carcinoma J Nat Prod 73 2010 1476 1481
    • (2010) J Nat Prod , vol.73 , pp. 1476-1481
    • Samadi, A.K.1    Tong, X.2    Mukerji, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.